The old-line movie factories essentially pursue one of two strategies. The dominant companies, Walt Disney Studios and Warner Bros., with their vast superhero holdings and ongoing franchises, focus on big-budget, all-audience films.
Studios with less access to pre-existing characters — 20th Century Fox, Universal Pictures — have it much harder, operating on more of an old-fashioned portfolio basis. They serve up a wide mix of movies and hope that some of those bets pay off.The power of the second approach was on vivid display over the weekend, as six starkly different films from 20th Century Fox appeared on the box office charts, giving the studio control of more than 50 percent of ticket sales in North America.
A sequel to a sequel, “Maze Runner: The Death Cure,” with its zombie plague and revenge-determined teenagers, arrived to about $23.5 million in ticket sales domestically, dethroning Sony’s “Jumanji: Welcome to the Jungle” as the No. 1 attraction at multiplexes. “The Death Cure,” which was delayed…
The post ‘Maze Runner’ Sequel is No. 1, Adding to Fox Box Office Bonanza appeared first on FeedBox.